KIF1B rs17401966: Understanding Liver Cancer Susceptibility Research
The rs17401966 variant is a single nucleotide polymorphism located within the KIF1B gene. It has been studied as a potential genetic marker for susceptibility to hepatocellular carcinoma (HCC), particularly among individuals with chronic hepatitis B virus (HBV) infection in Chinese populations.
What each genotype means
Baseline hepatocellular carcinoma risk
This genotype is considered the baseline or reference state in studies investigating this variant. Research suggests that individuals with this genotype may have a higher relative risk for hepatocellular carcinoma compared to those carrying the G allele, particularly in the context of chronic hepatitis B infection.
This is a common genotype observed in many populations, though frequency data varies significantly by ancestry.
Reduced hepatocellular carcinoma risk
Carrying one copy of the G allele is associated with a statistically significant reduction in the risk of developing hepatocellular carcinoma. This protective effect is most consistently observed in Chinese populations, especially among individuals who are chronic hepatitis B virus carriers.
This heterozygous genotype is frequently found in populations where the G allele is present.
Lower hepatocellular carcinoma risk
Individuals with this genotype carry two copies of the G allele, which has been identified as a protective factor against hepatocellular carcinoma in several studies. This association is most pronounced in Chinese cohorts and individuals with chronic hepatitis B, though the effect is not observed in all ethnic groups.
The frequency of this genotype varies by ancestry and is notably present in various Chinese populations.
What is the rs17401966 Variant?
The rs17401966 variant is a specific change in the DNA sequence of the KIF1B gene. In genetics, a single nucleotide polymorphism (SNP) represents a variation at a single position in the DNA chain. This particular variant involves a substitution of one nucleotide for another. Researchers track these variations to determine if they correlate with specific health traits or disease risks. The rs17401966 variant is located on chromosome 1, a region known for housing genes involved in various cellular processes. Because this variant is located in a non-coding or regulatory region of the gene, scientists investigate whether it influences how the KIF1B gene is expressed or regulated within liver cells. Understanding the location and nature of this SNP is the first step in determining its potential biological impact on human health.
The Role of the KIF1B Gene
The KIF1B gene encodes a protein known as kinesin family member 1B. Kinesins are motor proteins that play a critical role in intracellular transport, moving molecules and organelles along microtubules within cells. This transport system is essential for maintaining cellular structure, signaling, and division. Because of its role in these fundamental processes, the KIF1B gene has been studied for its potential involvement in tumor suppression. When the function of such a gene is altered, it may affect how cells grow, divide, or respond to stress, such as viral infections. In the context of liver health, researchers hypothesize that variations in KIF1B might influence the liver's ability to manage cellular damage or prevent the uncontrolled growth that characterizes cancer. However, the exact mechanism by which this specific SNP might influence liver cancer risk remains a subject of ongoing scientific investigation.
Research and Evidence Strength
The evidence linking rs17401966 to hepatocellular carcinoma (HCC) is considered moderate and highly dependent on ancestry. Initial studies identified a potential association, suggesting that the G allele might be associated with a decreased risk of HCC in Chinese populations, particularly those with chronic HBV infection. However, subsequent meta-analyses and replication studies have produced conflicting results. While some studies support a protective effect, others have failed to replicate these findings in different cohorts or other East Asian populations, such as Japanese or Korean groups. This inconsistency suggests that the variant's impact may be influenced by complex interactions between genetics, environmental factors like alcohol consumption, and the presence of viral infections. Because the results vary across different studies and populations, the scientific community emphasizes that this variant should not be viewed as a definitive predictor of disease risk.
What This Information Means for You
It is important to understand that genetic variants like rs17401966 are only one piece of a very complex puzzle. Most complex diseases, including liver cancer, are influenced by a combination of genetic, environmental, and lifestyle factors. Having a specific genotype does not mean an individual will or will not develop a disease. This information is primarily used in research settings to understand biological pathways and population-level trends. It is not a diagnostic tool for clinical use. If you are concerned about your liver health or your risk for specific conditions, the most effective approach is to consult with a healthcare professional. They can provide personalized guidance based on your medical history, lifestyle, and clinical screenings. Never use genetic research findings to make medical decisions or change your health habits without professional medical advice.
How common is this variant?
The rs17401966 variant is primarily studied in Chinese populations, where the frequency of the alleles varies. Research indicates that the association with HCC risk is not consistently observed across non-Chinese or other East Asian populations.
Frequently asked questions
Does having the rs17401966 variant mean I will get liver cancer?
No. Genetic variants are only one of many factors that contribute to disease risk. Most people with a specific genotype will never develop the associated condition, as environmental and lifestyle factors play a much larger role.
Is this genetic test used for clinical diagnosis?
No. The rs17401966 variant is currently a subject of scientific research. It is not used in clinical practice to diagnose liver cancer or to determine an individual's personal risk.
Why do studies show different results for this variant?
Conflicting results are common in genetic research due to differences in study design, sample sizes, and the genetic background of the populations studied. Additionally, complex interactions between genes and the environment can make it difficult to replicate findings across different groups.
Should I be worried if I have the AA genotype?
There is no reason for concern based on a single genetic variant. Genetic associations are statistical observations in large groups, not individual predictions. If you have concerns about your liver health, please speak with your doctor about appropriate screenings.
Sources & further reading
Educational information only, last refreshed 10/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17401966?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29